PMID- 31530256 OWN - NLM STAT- MEDLINE DCOM- 20201026 LR - 20201026 IS - 1557-9077 (Electronic) IS - 1050-7256 (Linking) VI - 29 IP - 12 DP - 2019 Dec TI - The In Vitro Functional Impairment of Thyroid Hormone Receptor Alpha 1 Isoform Mutants Is Mainly Dictated by Reduced Ligand Sensitivity. PG - 1834-1842 LID - 10.1089/thy.2019.0019 [doi] AB - Background: Thyroid hormone (TH) acts on TH receptors (TRs) and regulates gene transcription by binding of TRs to TH response elements (TREs) in target gene promoters. The transcriptional activity of TRs is modulated by interactions with TR-coregulatory proteins. Mutations in TRalpha cause resistance to thyroid hormone alpha (RTHalpha). In this study, we analyzed if, beyond reduced triiodothyronine (T3) affinity, altered interactions with cofactors or different TREs could account for the differential impaired transcriptional activity of different mutants. Methods: We evaluated four mutants derived from patients (D211G, M256T, A263S, and R384H) and three artificial mutants at equivalent positions in patients with RTHbeta (T223A, L287V, and P398H). The in vitro transcriptional activity was evaluated on TRE-luciferase reporters (DR4, IR0, and ER6). The affinity for T3 and interaction with coregulatory proteins (nuclear receptor corepressor 1 [NCoR1] and steroid receptor coactivator 1 [SRC1]) were also determined. Results: We found that the affinity for T3 was significantly reduced for all mutants, except for TRalpha1-T223A. The reduction in the T3 sensitivity of the transcriptional activity on three TREs, the dissociation of the corepressor NCoR1, and the association of the coactivator SRC1 recruitment for each mutant correlated with the reduced affinity for T3. We did not observe mutation-specific alterations in interactions with cofactors or TREs. Conclusions: In summary, the degree of impaired transcriptional activity of mutants is mainly determined by their reduced affinity for T3. FAU - Wejaphikul, Karn AU - Wejaphikul K AD - Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus MC, Rotterdam, The Netherlands. AD - Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. FAU - van Gucht, Anja L M AU - van Gucht ALM AD - Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus MC, Rotterdam, The Netherlands. FAU - Groeneweg, Stefan AU - Groeneweg S AD - Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus MC, Rotterdam, The Netherlands. FAU - Visser, W Edward AU - Visser WE AD - Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus MC, Rotterdam, The Netherlands. FAU - Visser, Theo J AU - Visser TJ AD - Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus MC, Rotterdam, The Netherlands. FAU - Peeters, Robin P AU - Peeters RP AD - Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus MC, Rotterdam, The Netherlands. FAU - Meima, Marcel E AU - Meima ME AD - Department of Internal Medicine, Academic Center for Thyroid Diseases, Erasmus MC, Rotterdam, The Netherlands. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20191119 PL - United States TA - Thyroid JT - Thyroid : official journal of the American Thyroid Association JID - 9104317 RN - 0 (Ligands) RN - 0 (NCOR1 protein, human) RN - 0 (Nuclear Receptor Co-Repressor 1) RN - 0 (Thyroid Hormone Receptors alpha) RN - 06LU7C9H1V (Triiodothyronine) RN - EC 2.3.1.48 (NCOA1 protein, human) RN - EC 2.3.1.48 (Nuclear Receptor Coactivator 1) SB - IM MH - Cell Line, Tumor MH - Computer Simulation MH - Humans MH - Ligands MH - Models, Molecular MH - Mutation/*genetics MH - Nuclear Receptor Co-Repressor 1/genetics MH - Nuclear Receptor Coactivator 1/genetics MH - Protein Binding MH - Response Elements MH - Thyroid Hormone Receptors alpha/*genetics/*metabolism MH - Transcription, Genetic MH - Triiodothyronine/metabolism OTO - NOTNLM OT - coregulatory proteins OT - receptor mutation OT - resistance to thyroid hormone OT - thyroid hormone action OT - thyroid hormone receptor OT - thyroid hormone response elements EDAT- 2019/09/19 06:00 MHDA- 2020/10/27 06:00 CRDT- 2019/09/19 06:00 PHST- 2019/09/19 06:00 [pubmed] PHST- 2020/10/27 06:00 [medline] PHST- 2019/09/19 06:00 [entrez] AID - 10.1089/thy.2019.0019 [doi] PST - ppublish SO - Thyroid. 2019 Dec;29(12):1834-1842. doi: 10.1089/thy.2019.0019. Epub 2019 Nov 19.